Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
Enter Symbol
Company
Overview
Research Notes
Company Profile
Competitors
Community
Wiki
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Related News
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
29M
Market Cap:
$0.01B
Avg Volume:
168592
P/E Ratio:
-0.010
PEG Ratio:
-0.010
Trade now with
1m
3m
6m
1y
2y
Opinion and Analysis
Downtrend Continues
Jun 16, 2011 01:19 AM |
AAPL
,
AMZN
,
CDTI
,
CMED
,
CREE
,
ETN
52-Week Lows: NGSX, CEDC, OWW, YRCW, RST
Mar 01, 2011 02:04 PM |
CEDC
,
NGSX
,
OWW
,
YRCW
Seven Bear Stocks In Healthcare Sector
Feb 18, 2011 09:41 AM |
CYTK
,
DSCO
,
MNOV
,
NGSX
52-Week Highs & Lows: TDSC, INPH, HDNG, WTW, TBL, IO, NGSX, TSTY, ARL, OWW
Feb 17, 2011 09:14 PM |
ARL
,
HDNG
,
INPH
,
IO
,
NGSX
,
OWW
Volume Talks Wednesday: A Bullish Biotech Breakout Option Play
Mar 25, 2010 10:30 AM |
ABVT
,
AGO
,
BLK
,
BRS
,
CCL
,
CPD
More Articles on NGSX..
Market News
NeurogesX receives notice of allowance for neuropathic pain product
Apr 28, 2011 10:53 AM |
NGSX
More News on NGSX..
Press Releases
NeurogesX Reports First Quarter 2012 Results
May 03, 2012 04:05 PM |
NGSX
Robbins Umeda LLP Announces an Investigation of NeurogesX, Inc.
May 03, 2012 12:27 PM |
NGSX
NeurogesX to Hold Conference Call to Discuss First Quarter 2012 Results
Apr 27, 2012 09:00 AM |
NGSX
More Press Releases on NGSX..
SEC Filings
Form 4/A NeurogesX Inc For: Mar 13 Filed by: Peroutka Stephen J (10K)
Mar 16, 2012 07:27 PM
Form 4 NeurogesX Inc For: Mar 13 Filed by: MARTELL RON (10K)
Mar 15, 2012 09:58 PM
Form 4 NeurogesX Inc For: Mar 13 Filed by: Markels Michael (10K)
Mar 15, 2012 09:50 PM
More SEC Filings on NGSX..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
NGSX
Compare to S&P
YTD
-49.34 %
-46.32 %
4 Weeks
-3.23 %
-2.34 %
12 Weeks
-32.78 %
-33.65 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-2.94 %
EPS Growth in Last Year:
53.33 %
Sales Growth in Last Quarter:
0.47 %
Sales Growth in Last Quarter:
-6.21 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##